iX Biopharma closes in on US military approval for pain drug
This page is a curated summary. Full reporting lives at the publisher linked below. We do not reproduce their article in full.
The company says it expects to complete its Emergency Use Authorization submission in Q4 [SINGAPORE] iX Biopharma is clearing the path for its sublingual ketamine wafer to treat military casualties. . .
The company says it expects to complete its Emergency Use Authorization submission in Q4 [SINGAPORE] iX Biopharma is clearing the path for its sublingual ketamine wafer to treat military casualties af...(+1930 chars hidden)
Related stories
Best Indie Horror Games Under $10 on Steam: Sale and Regular Prices
Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you. Yes—there are stron…
Child Saw Disturbing Video Game Content? What Parents Should Do
Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you. If your child has j…
A Sustainable Post-Launch Update Plan for Indie Games
Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you. Plan post-launch up…
Air Treatment Appliance Market: Growth Trends, Opportunities, and Forecast to 2032
The air treatment appliance market is projected to reach USD 32.78 billion by 2032 from USD 20.92 billion in 2026, at a CAGR of 7.8% during…